ERBB2 and breast carcinoma: To explore the potential significance of CXCL13 in young breast cancer, correlation analysis was performed in 152 clinical tissue specimens with breast cancer to assess the association of CXCL13 expression with clinicopathological features, including tumor grade, lymph node status, ER status, PR status and HER2 status.